Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.30 | -$0.28 | -$0.29 |
Q2 2024 | 1 | -$0.29 | -$0.26 | -$0.28 |
Q3 2024 | 1 | -$0.27 | -$0.24 | -$0.26 |
Q4 2024 | 1 | -$0.24 | -$0.21 | -$0.23 |
Q1 2025 | 1 | -$0.22 | -$0.20 | -$0.21 |
Q2 2025 | 1 | -$0.22 | -$0.20 | -$0.21 |
Q3 2025 | 1 | -$0.23 | -$0.21 | -$0.22 |
Q4 2025 | 1 | -$0.24 | -$0.22 | -$0.23 |
Rapid Micro Biosystems, Inc. last posted its earnings results on Friday, November 1st, 2024. The company reported $-0.26 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26 by $0. The company had revenue of 7.60 M for the quarter and had revenue of 22.52 M for the year. Rapid Micro Biosystems, Inc. has generated $-1 earnings per share over the last year ($-1.22 diluted earnings per share) and currently has a price-to-earnings ratio of -0.86. Rapid Micro Biosystems, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.26 | $6.55 M | $7.60 M | ||
08/02/2024 | Q2 2024 | -$0.28 | -$0.29 | -0.01 | $6.00 M | $6.62 M |
05/03/2024 | Q1 2024 | -$0.29 | -$0.31 | -0.02 | $5.61 M | |
03/01/2024 | Q4 2023 | -$0.31 | -$0.26 | 0.05 | $6.34 M | |
11/03/2023 | Q3 2023 | -$0.32 | -$0.31 | 0.01 | $5.55 M | $6.15 M |
08/04/2023 | Q2 2023 | -$0.36 | -$0.33 | 0.03 | $4.15 M | $5.00 M |
05/09/2023 | Q1 2023 | -$0.32 | $5.04 M | |||
03/10/2023 | Q4 2022 | -$0.39 | $4.37 M | |||
11/10/2022 | Q3 2022 | -$0.37 | -$0.38 | -0.01 | $3.97 M | $4.74 M |
08/12/2022 | Q2 2022 | -$0.35 | -$0.31 | 0.04 | $4.35 M | $3.86 M |
05/10/2022 | Q1 2022 | -$0.33 | -$0.35 | -0.02 | $4.16 M | |
03/24/2022 | Q4 2021 | -$0.35 | $5.21 M | |||
11/15/2021 | Q3 2021 | -$0.71 | $6.57 M | $6.90 M | ||
08/27/2021 | Q2 2021 | -$0.31 | $5.93 M | $6.13 M | ||
03/30/2021 | Q1 2021 | -$0.70 | $5.00 M | |||
12/31/2020 | Q4 2020 | -$0.36 | $5.24 M | |||
09/29/2020 | Q3 2020 | -$0.27 | $5.25 M | |||
06/29/2020 | Q2 2020 | -$0.29 | $2.59 M | |||
03/30/2020 | Q1 2020 | -$0.25 | $3.00 M |
Rapid Micro Biosystems, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
The conference call for Rapid Micro Biosystems, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Rapid Micro Biosystems, Inc.'s latest earnings report can be read online.
Rapid Micro Biosystems, Inc. (:RPID) has a recorded annual revenue of $22.52 M.
Rapid Micro Biosystems, Inc. (:RPID) has a recorded net income of $22.52 M. Rapid Micro Biosystems, Inc. has generated $-1.22 earnings per share over the last four quarters.
Rapid Micro Biosystems, Inc. (:RPID) has a price-to-earnings ratio of -0.86 and price/earnings-to-growth ratio is -0.2.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED